Five Prime Therapeutics Inc (NASDAQ:FPRX)

24.16
Delayed Data
As of Apr 17
 +1.66 / +7.38%
Today’s Change
10.50
Today|||52-Week Range
28.47
-10.52%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$616.9M

Company Description

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on discovering and developing novel protein therapeutics. It is building a pipeline of oncology and immunology drug by using its discovery platform. The company was founded in December 2001 by Lewis T. Williams and is headquartered in South San Francisco, CA.

Contact Information

Five Prime Therapeutics, Inc.
Two Corporate Drive
South San Francisco California 94080-7047
P:(415) 365-5600
Investor Relations:

Employees

Shareholders

Other institutional30.26%
Mutual fund holders22.91%
Individual stakeholders10.13%

Top Executives

Lewis T. WilliamsPresident, Chief Executive Officer & Director
Marc L. BelskyChief Financial Officer & Senior Vice President
William Michael KavanaughChief Scientific Officer & Senior VP-Research
Julie HambletonChief Medical Officer & Senior Vice President
Aron M. KnickerbockerDirector, Chief Business Officer & Senior VP

To view my watchlist

Not a member yet?

Sign up now for a free account